Persistance and compliance with osteroporosis therapies among women in a commercially insured population in the United States
…, PL Juneau, L Spangler, FM Mirza, BS Stolshek - Journal of managed …, 2015 - jmcp.org
… Cheng, Spangler, and Stolshek are employees, and Mirza was an employee, of Amgen.
Study concept and design were contributed by Cheng, Stolshek, and Durden, with assistance …
Study concept and design were contributed by Cheng, Stolshek, and Durden, with assistance …
Assessing health-related quality-of-life and health state preference in persons with obesity: a validation study
…, MG Cisternas, DJ Pasta, BS Stolshek… - Quality of Life …, 1997 - Springer
The objective of this study was to assess the reliability, validity and responsiveness of a new
health-related quality-of-life (HRQOL) measure containing global and obesity-specific …
health-related quality-of-life (HRQOL) measure containing global and obesity-specific …
Impact of age and colony-stimulating factor use on hospital length of stay for febrile neutropenia in CHOP-treated non-Hodgkin's lymphoma
E Chrischilles, DJ Delgado, BS Stolshek… - Cancer …, 2002 - journals.sagepub.com
Background In intermediate-grade non-Hodgkin's lymphoma (NHL) patients, full-dose
CHOP improves survival but increases myelosuppression, causing febrile neutropenia …
CHOP improves survival but increases myelosuppression, causing febrile neutropenia …
[PDF][PDF] Days of prophylactic filgrastim use to reduce febrile neutropenia in patients
SJ Scott, BS Stolshek, M Fridman, DJ Delgado… - Journal of managed …, 2003 - jmcp.org
… Delgado and Bradley S. Stolshek are employees and shareholders of Amgen, and Scott …
Drafting of the manuscript was the work of Delgado, Scott, Stolshek, and Fridman; critical …
Drafting of the manuscript was the work of Delgado, Scott, Stolshek, and Fridman; critical …
[HTML][HTML] Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry
LR Harrold, BS Stolshek, S Rebello, DH Collier… - Clinical …, 2017 - Springer
Psoriatic arthritis (PsA) is a chronic condition characterized by a diverse set of symptoms, from
swollen joints to nail disease to skin disease. A variety of treatment options are available, …
swollen joints to nail disease to skin disease. A variety of treatment options are available, …
Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan
SW Wade, JR Curtis, J Yu, J White, BS Stolshek… - Bone, 2012 - Elsevier
The association between bisphosphonate adherence in the first 12months after therapy
initiation and subsequent fracture risk was examined. Patients were identified from a large, …
initiation and subsequent fracture risk was examined. Patients were identified from a large, …
Osteoporosis medication adherence: physician perceptions vs. patients' utilization
JR Curtis, Q Cai, SW Wade, BS Stolshek, JL Adams… - Bone, 2013 - Elsevier
Few data are available on physician perceptions of osteoporosis medication adherence.
This study compared physician-estimated medication adherence with adherence calculated …
This study compared physician-estimated medication adherence with adherence calculated …
[HTML][HTML] A retrospective cohort study comparing utilization and costs of biologic therapies and JAK inhibitor therapy across four common inflammatory indications in …
…, J White, D Van Voorhis, D Tang, BS Stolshek - Advances in …, 2016 - Springer
Introduction Biologic therapies are used to treat several inflammatory diseases, including
rheumatoid arthritis (RA), psoriasis (PsO), psoriatic arthritis (PsA), and ankylosing spondylitis (…
rheumatoid arthritis (RA), psoriasis (PsO), psoriatic arthritis (PsA), and ankylosing spondylitis (…
Direct healthcare costs of osteoporosis-related fractures in managed care patients receiving pharmacological osteoporosis therapy
…, JR Curtis, J Yu, J White, BS Stolshek… - … health economics and …, 2012 - Springer
Background Osteoporosis is a common condition and the economic burden of osteoporosis-related
fractures is significant. While studies have reported the incremental or attributable …
fractures is significant. While studies have reported the incremental or attributable …
[HTML][HTML] Impact of osteoporosis on high-cost chronic diseases
SW Thayer, BS Stolshek, GG Rey, JG Seare - Value in Health, 2014 - Elsevier
Objective To assess the impact of osteoporosis on health care costs for patients with chronic
disease (CD): cardiovascular disease (CVD), chronic obstructive pulmonary disease (COPD…
disease (CD): cardiovascular disease (CVD), chronic obstructive pulmonary disease (COPD…